Kyverna Therapeutics, Inc. · NASDAQ:KYTX
Bain Capital Life Sciences Opportunities III, LP reported a 5.40% stake in Kyverna Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Bain Capital Life Sciences Opportunities III, LP reported a 5.40% stake in Kyverna Therapeutics, Inc., 3,110,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 5.40%
- Shares
- 3,110,000
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bain Capital Life Sciences Opportunities III, LP | 5.40% | 3,110,000 |
Source
Related
- Kyverna Therapeutics, Inc.
- Bain Capital Life Sciences Opportunities III, LP
- Kyverna Therapeutics, Inc. shareholders
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G · Orin Hirschman · Oct 19, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Clark Ian T · May 29, 2026
- Form 4 · Cohen Fred E · May 29, 2026
- Form 4 · Seidenberg Beth C · May 29, 2026